CN104744479A - 一种喹唑啉酮并二氢吡唑化合物及其制备方法 - Google Patents
一种喹唑啉酮并二氢吡唑化合物及其制备方法 Download PDFInfo
- Publication number
- CN104744479A CN104744479A CN201510167242.4A CN201510167242A CN104744479A CN 104744479 A CN104744479 A CN 104744479A CN 201510167242 A CN201510167242 A CN 201510167242A CN 104744479 A CN104744479 A CN 104744479A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- preparation
- organic solvent
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 65
- 150000001875 compounds Chemical class 0.000 title claims abstract description 60
- 239000003960 organic solvent Substances 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 63
- 238000006243 chemical reaction Methods 0.000 claims description 46
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 32
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 19
- 239000003513 alkali Substances 0.000 claims description 18
- 238000010189 synthetic method Methods 0.000 claims description 17
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 12
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical compound C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 claims description 11
- 239000005457 ice water Substances 0.000 claims description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- -1 pyrazoline compound Chemical class 0.000 claims description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- 235000019253 formic acid Nutrition 0.000 claims description 6
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 6
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 235000015320 potassium carbonate Nutrition 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 claims description 3
- KGWDUNBJIMUFAP-KVVVOXFISA-N Ethanolamine Oleate Chemical compound NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O KGWDUNBJIMUFAP-KVVVOXFISA-N 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 239000007787 solid Substances 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 17
- 235000019441 ethanol Nutrition 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 14
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- 238000001953 recrystallisation Methods 0.000 description 10
- 238000001291 vacuum drying Methods 0.000 description 10
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000011010 flushing procedure Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000005352 clarification Methods 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- VHFPVEGFRVEDBK-SNAWJCMRSA-N (e)-3-(6-methylsulfanyl-4-oxoquinazolin-3-yl)prop-2-enoic acid Chemical compound N1=CN(\C=C\C(O)=O)C(=O)C2=CC(SC)=CC=C21 VHFPVEGFRVEDBK-SNAWJCMRSA-N 0.000 description 2
- VDOSWXIDETXFET-UHFFFAOYSA-N Afloqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC(N)=CC=C2N=C1CF VDOSWXIDETXFET-UHFFFAOYSA-N 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- 102000005497 Thymidylate Synthase Human genes 0.000 description 2
- 229950009353 afloqualone Drugs 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- SFITWQDBYUMAPS-UHFFFAOYSA-N mecloqualone Chemical compound CC1=NC2=CC=CC=C2C(=O)N1C1=CC=CC=C1Cl SFITWQDBYUMAPS-UHFFFAOYSA-N 0.000 description 2
- 229950007403 mecloqualone Drugs 0.000 description 2
- 150000002941 palladium compounds Chemical class 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229950011055 tiacrilast Drugs 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- ODQVVRUVKWYXKN-UHFFFAOYSA-N 2H-indazolo[3,2-b]quinazolin-1-one Chemical class C1=CC=CC2=NC3=C4C(=O)CC=CC4=NN3C=C21 ODQVVRUVKWYXKN-UHFFFAOYSA-N 0.000 description 1
- OLAKUHHSMYDYQE-UHFFFAOYSA-N 6,8-dihydro-5h-quinazolin-7-one Chemical compound N1=CN=C2CC(=O)CCC2=C1 OLAKUHHSMYDYQE-UHFFFAOYSA-N 0.000 description 1
- 239000005476 Bentazone Substances 0.000 description 1
- 0 C=P**(C(C1=CC(C*N)CC=C1)=*C1=CCCC=C11)C1=O Chemical compound C=P**(C(C1=CC(C*N)CC=C1)=*C1=CCCC=C11)C1=O 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- CUVRDUOPLLMXDL-UHFFFAOYSA-N N1C=CC2=CC=C3C(=C12)C=CC=C3.N3C(N=CC1=CC=CC=C31)=O Chemical class N1C=CC2=CC=C3C(=C12)C=CC=C3.N3C(N=CC1=CC=CC=C31)=O CUVRDUOPLLMXDL-UHFFFAOYSA-N 0.000 description 1
- TYKQGPCRBPGVEF-UHFFFAOYSA-N N1N=CC2=CC=CC=C12.N1C(N=CC2=CC=CC=C12)=O Chemical class N1N=CC2=CC=CC=C12.N1C(N=CC2=CC=CC=C12)=O TYKQGPCRBPGVEF-UHFFFAOYSA-N 0.000 description 1
- IVTVGDXNLFLDRM-HNNXBMFYSA-N Tomudex Chemical compound C=1C=C2NC(C)=NC(=O)C2=CC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)S1 IVTVGDXNLFLDRM-HNNXBMFYSA-N 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- ZOMSMJKLGFBRBS-UHFFFAOYSA-N bentazone Chemical compound C1=CC=C2NS(=O)(=O)N(C(C)C)C(=O)C2=C1 ZOMSMJKLGFBRBS-UHFFFAOYSA-N 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzidamine Natural products C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- UVTJKLLUVOTSOB-UHFFFAOYSA-N etaqualone Chemical compound CCC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C UVTJKLLUVOTSOB-UHFFFAOYSA-N 0.000 description 1
- 229950010472 etaqualone Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- VYFOAVADNIHPTR-UHFFFAOYSA-N isatoic anhydride Chemical class NC1=CC=CC=C1CO VYFOAVADNIHPTR-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229960004432 raltitrexed Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510167242.4A CN104744479B (zh) | 2015-04-10 | 2015-04-10 | 一种喹唑啉酮并二氢吡唑化合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510167242.4A CN104744479B (zh) | 2015-04-10 | 2015-04-10 | 一种喹唑啉酮并二氢吡唑化合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104744479A true CN104744479A (zh) | 2015-07-01 |
CN104744479B CN104744479B (zh) | 2017-03-15 |
Family
ID=53584811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510167242.4A Expired - Fee Related CN104744479B (zh) | 2015-04-10 | 2015-04-10 | 一种喹唑啉酮并二氢吡唑化合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104744479B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103664963A (zh) * | 2013-12-23 | 2014-03-26 | 温州大学 | 一种喹唑啉酮并吲唑衍生物的合成方法 |
CN103980280A (zh) * | 2014-04-22 | 2014-08-13 | 温州大学 | 一种酸性条件下合成喹唑啉酮并吲唑衍生物的方法 |
-
2015
- 2015-04-10 CN CN201510167242.4A patent/CN104744479B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103664963A (zh) * | 2013-12-23 | 2014-03-26 | 温州大学 | 一种喹唑啉酮并吲唑衍生物的合成方法 |
CN103980280A (zh) * | 2014-04-22 | 2014-08-13 | 温州大学 | 一种酸性条件下合成喹唑啉酮并吲唑衍生物的方法 |
Non-Patent Citations (4)
Title |
---|
J. B. JIANG,ET AL.,: "Synthesis and Biological Evaluation of 2-Styrylquinazolin-4( 3H)-ones, a New Class of Antimitotic Anticancer Agents Which Inhibit Tubulin Polymerization", 《J. MED. CHEM.》 * |
JOHN T. GUPTON,ET AL.,: "A REINVESTIGATION OF THE REACTION OF HYDRAZINE HYDRATE WITH 2-SUBSTITUTED STYRYL-4-QUINAZOLONES", 《SYNTHETIC COMMUNICATIONS》 * |
MOHAMMAD S.KHAJAVI,ET AL.,: "A new synthesis of 2-substituted 4H-3,1-benzoxazin-4-ones by cyanuric chloride cyclodehydration of n-benzoyl- and n-acylanthranilic acids", 《HETEROCYCLES》 * |
VIKAS SRIVASTAVA,ET AL.,: "Disubstituted 4(3H) Quinazolones: A Novel Class of Antitumor Agents", 《CHEM BIOL DRUG DES》 * |
Also Published As
Publication number | Publication date |
---|---|
CN104744479B (zh) | 2017-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
El‐Hawash et al. | Synthesis of Some New Quinoxalines and 1, 2, 4‐Triazolo [4, 3‐a]‐quinoxalines for Evaluation of in vitro Antitumor and Antimicrobial Activities | |
CN112272666A (zh) | 用于治疗癌症的化合物 | |
CN103819413A (zh) | 含喹唑啉酮芳氧基的戊二烯酮类化合物及制备方法和应用 | |
CN104725325B (zh) | 一种2‑(1‑苯乙基)喹唑啉酮及其催化合成方法 | |
JP2009527515A (ja) | 新規のピリジン−3−アミン誘導体 | |
CA3218824A1 (en) | Stapled peptides and methods thereof | |
JPWO2002026745A1 (ja) | チエノピリミジン化合物とその塩並びに製造方法 | |
CN104744479A (zh) | 一种喹唑啉酮并二氢吡唑化合物及其制备方法 | |
CN104016929B (zh) | 一种合成喹唑啉-4(3h)-酮的方法 | |
CN106008373A (zh) | 二取代双环衍生物及其作为外排泵抑制剂在抗菌中的应用 | |
Bhanat et al. | Microwave Induced Synthesis and Antimicrobial activities of various substituted Pyrazolidines from Chalcones | |
Darwish et al. | Synthesis and antimicrobial evaluation of some isoxazole based heterocycles | |
CN104725385A (zh) | 一种喹唑啉酮并吡唑化合物及其合成方法 | |
CN104710368B (zh) | 一种2‑苯甲酰基喹唑啉酮化合物的合成方法 | |
Attaby et al. | Reactions of cyanothioacetamide: synthesis of several new thioxohydro-pyridine-3-carbonitrile and thieno [2, 3-b] pyridine derivatives | |
CN104761506B (zh) | 一种2‑(1‑苯乙烯基)喹唑啉酮化合物及其合成方法 | |
Lee et al. | Synthesis and biological properties of selected 2-aryl-4 (3H)-quinazolinones | |
CN104761558B (zh) | 一种一锅法合成喹唑啉酮并吲唑衍生物的方法 | |
Gad-Elkareem et al. | Pyridine-2 (1 H)-thione in Heterocyclic Synthesis: Synthesis of Some New Nicotinic Acid Ester, Thieno [2, 3-b] pyridine, Pyrido [3′, 2′: 4, 5] thieno [3, 2-d] pyrimidine, and Thiazolylpyrazolo [3, 4-b] pyridine Derivatives | |
Ren et al. | Synthesis of a small library containing substituted pyrazoles | |
CN101781295B (zh) | 5-氨基-1,2,4-噻二唑类化合物及其制备方法 | |
Wang et al. | Ultrasound-assisted synthesis and preliminary bioactivity of novel 2H-1, 2, 4-thiadiazolo [2, 3-a] pyrimidine derivatives containing fluorine | |
Khunt et al. | Synthesis and characterization of fully substituted pyrimidines by using ketene dithioacetal as potent antimicrobial agent | |
Shepherd et al. | o-Nitrobenzylidene compounds. Part 4. The cyanide-induced cyclisation of o-acetamido-N-(o-nitrobenzylidene) anilines: an improved route to quinoxalino [2, 3-c] cinnolines | |
CN105439979B (zh) | 含1,2,3‑噻二唑的苯甲酰腙衍生物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Jiuxi Inventor after: Qiao Rui Inventor after: Yang Weiguang Inventor after: Chen Fanglin Inventor after: Wu Huayue Inventor before: Qiao Rui Inventor before: Chen Jiuxi Inventor before: Yang Weiguang Inventor before: Chen Fanglin Inventor before: Wu Huayue |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170315 |
|
CF01 | Termination of patent right due to non-payment of annual fee |